Allelic variant in the glucagon ‐like peptide 1 receptor gene associated with greater effect of liraglutide and exenatide on gastric emptying: A pilot pharmacogenetics study
Conclusions & InferencesThe minor A allele of GLP1R (rs6923761) is associated with greater delay in GE T1/2 in response to liraglutide and exenatide. These studies provide data to plan pharmacogenetics testing of the hypothesis that GLP1R (rs6923761) influences weight loss in response to GLP1R agonists.
The degree of weight loss is associated with greater delay in gastric‐emptying T1/2 in response to liraglutide and exenatide. The minor A allele of GLP1R (rs6923761) was associated with higher weight loss with liraglutide treatment. These studies provide data to plan pharmacogenetics testing of the hypothesis that GLP1R (rs6923761) influences weight loss in response to GLP1R agonists.
Source: Neurogastroenterology and Motility - Category: Gastroenterology Authors: V. Chedid, P. Vijayvargiya, P. Carlson, K. Van Malderen, A. Acosta, A. Zinsmeister, M. Camilleri Tags: ORIGINAL ARTICLE Source Type: research
More News: Brain | Byetta | Eating Disorders & Weight Management | Gastroenterology | Genetics | Neurology | Obesity | Study | Victoza | Weight Loss